Figure S7 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors — Ismael A. Vergara (2025) | RDL Network
Figure S7 from Discovery and Validation of an Ancillary Genomic Test of Malignancy for Primary Melanocytic Tumors
Article 2025 en
Authors
IV
Ismael A. Vergara
NM
Nigel Maher
AP
Alison J. Potter
Abstract
1 min read
<p>Scatter plot of mean target coverage and mean number of unique start sites across targets for borderline melanocytic tumors. Samples with a coverage below 300X (square shape) were deemed outliers and removed from further analysis.</p>
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Ismael A. Vergara, Nigel Maher, Alison J. Potter, Elizabeth C. Paver, Jordan W. Conway, Serigne Lo, Andrew J. Colebatch, Georgina V. Long, James S. Wilmott, Richard A Scolyer
Discussion(0)
No comments yet. Be the first to comment.